[HTML][HTML] Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016

A Lugli, R Kirsch, Y Ajioka, F Bosman, G Cathomas… - Modern pathology, 2017 - Elsevier
Tumor budding is a well-established independent prognostic factor in colorectal cancer but
a standardized method for its assessment has been lacking. The primary aim of the …

[HTML][HTML] Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus

R Adam, A de Gramont, J Figueras, N Kokudo… - Cancer treatment …, 2015 - Elsevier
An international panel of multidisciplinary experts convened to develop recommendations
for managing patients with colorectal cancer (CRC) and synchronous liver metastases …

Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort …

AG Renehan, L Malcomson, R Emsley… - The Lancet …, 2016 - thelancet.com
Background Induction of a clinical complete response with chemoradiotherapy, followed by
observation via a watch-and-wait approach, has emerged as a management option for …

[HTML][HTML] Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212): a multicenter, randomized controlled …

S Fujita, J Mizusawa, Y Kanemitsu, M Ito… - Annals of …, 2017 - journals.lww.com
Objective: The aim of the study was to confirm the noninferiority of mesorectal excision (ME)
alone to ME with lateral lymph node dissection (LLND) in terms of efficacy. Background …

[HTML][HTML] Deep submucosal invasion is not an independent risk factor for lymph node metastasis in T1 colorectal cancer: a meta-analysis

LW Zwager, BAJ Bastiaansen, NSM Montazeri… - Gastroenterology, 2022 - Elsevier
Background & Aims Deep submucosal invasion (DSI) is considered a key risk factor for
lymph node metastasis (LNM) and important criterion to recommend surgery in T1 colorectal …

Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer (JCOG0404): a phase 3, randomised controlled trial

S Kitano, M Inomata, J Mizusawa… - The lancet …, 2017 - thelancet.com
Background Although benefits of laparoscopic surgery compared with open surgery have
been suggested, the long-term survival of patients undergoing laparoscopic surgery for …

Treatment of patients with late-stage colorectal cancer: ASCO resource-stratified guideline

EG Chiorean, G Nandakumar, T Fadelu… - JCO Global …, 2020 - ascopubs.org
PURPOSE To provide expert guidance to clinicians and policymakers in resource-
constrained settings on the management of patients with late-stage colorectal cancer …

Results of a randomized, double-blind, placebo-controlled, phase III trial of trifluridine/tipiracil (TAS-102) monotherapy in Asian patients with previously treated …

J Xu, TW Kim, L Shen, V Sriuranpong, H Pan… - Journal of Clinical …, 2018 - ascopubs.org
Purpose Trifluridine/tipiracil (TAS-102) was effective in patients with metastatic colorectal
cancer (mCRC) in a phase II Japanese trial. This regional trial evaluated the efficacy and …

Comprehensive review on naringenin and naringin polyphenols as a potent anticancer agent

A Rauf, MA Shariati, M Imran, K Bashir… - … Science and Pollution …, 2022 - Springer
Though the incidence of several cancers in Western societies is regulated wisely, some
cancers such as breast, lung, and colorectal cancer are currently rising in many low-and …

Clinical significance of the C-reactive protein to albumin ratio for survival after surgery for colorectal cancer

M Ishizuka, H Nagata, K Takagi, Y Iwasaki… - Annals of surgical …, 2016 - Springer
Objective This study was designed to estimate the clinical significance of the C-reactive
protein (CRP)/albumin ratio (CAR) for prediction of postoperative survival in patients with …